top of page
Cult Food Science's Unicorn Biotechnologies unveils non-GMO cell line, secures commercial partnership
Technology

Cult Food Science's Unicorn Biotechnologies unveils non-GMO cell line, secures commercial partnership

Research: Is cell-based meat a threat or an opportunity for UK farmers?
Meat

Research: Is cell-based meat a threat or an opportunity for UK farmers?

Opinion: Alternative proteins – can advanced analytics answer the unanswered?
Manufacturing

Opinion: Alternative proteins – can advanced analytics answer the unanswered?

Imperial College London to host UK's first Bezos Centre for Sustainable Protein
Precision fermentation

Imperial College London to host UK's first Bezos Centre for Sustainable Protein

Related posts

UK-based start-up Uncommon – formerly Higher Steaks – has raised $30 million in Series A funding, led by Balderton Capital and Lowercarbon.


The funding includes participation from Red Alpine and East Alpha will be used to further develop Uncommon’s novel approach, scale-up production at its pilot manufacturing facility in Cambridge, UK, and begin the regulatory approvals process for its cell-based pork.


founders of Uncommon
Ruth Faram and Benjamina Bollag, co-founders of Uncommon

Founded by Benjamina Bollag and Ruth Faram, Uncommon leverages RNA, the molecule that contains the chemical instructions that direct cells’ natural machinery into making a protein, to create delicious cultivated bacon and pork belly from animal cells.


Bollag said: “Uncommon [is] a biocreation company that uses the power of cells to tackle the most pressing challenges to our health, starting with cultivated pork. As the only cultivated meat leveraging RNA technologies, we believe we have a competitive advantage that could help us become the largest protein company in the world.”


The company says that its unique approach enables it to “more quickly reach price parity with conventional meat, scale faster and create safer, healthier products without the use of gene editing,” which it says will open up a wider global market than its competitors.


Uncommon’s extensive research used insights to build complex proteins and fats that possess “authentic flavour” and nutritional benefits. This technology does not require the need for antibiotics, animal products or toxic small molecules, and reduces the raw materials needed for alt-protein production.


Uncommon bacon
Uncommon's cell-based bacon

In a statement, the company said: “With over a third of the world’s total antibiotics used solely on pigs in China, and antibiotic resistance predicted to kill more people than cancer by 2050, cultivated meat offers a sustainable solution”.


Daniel Waterhouse, partner at Balderton Capital, commented: “The cultivated meat industry faces significant challenges, from the cost of materials to regulation and scaling. We’re convinced that Uncommon has the formula to become a global leader that will transform how we eat and enjoy meat.”


Clea Kolster, partner at Lowercarbon, added: “The meat industry is one of the biggest sources of carbon emissions globally and industrial production is also tied to infectious diseases like swine fever and bird flu. Uncommon is on a mission to build a healthier future by leveraging RNA technologies to create cultivated pork belly and bacon, which could produce up to 52% fewer carbon emissions per pound than traditional pork.”


#Uncommon #HigherSteaks #UK


Uncommon raises $30m to scale cell-based meat production

Phoebe Fraser

14 June 2023

Uncommon raises $30m to scale cell-based meat production

bottom of page